Mitsubishi Ufj Trust & Banking Corp Amgen Inc Transaction History

Mitsubishi Ufj Trust & Banking Corp

$43.3 Billion
Q1 2024

A detailed history of Mitsubishi Ufj Trust & Banking Corp transactions in Amgen Inc stock. As of the latest transaction made, Mitsubishi Ufj Trust & Banking Corp holds 414,636 shares of AMGN stock, worth $130 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

414,636

Previous 532,311 22.11%

Holding current value

$130 Million

Previous $153 Million 23.11%

% of portfolio

0.27%

Previous 0.36%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$268.87 - $324.56 $31.6 Million - $38.2 Million	-117,675 Reduced 22.11%	414,636 $118 Million
Q4 2023 Feb 09, 2024	SELL	$255.7 - $288.46 $1.7 Million - $1.91 Million	-6,630 Reduced 1.23%	532,311 $153 Million
Q3 2023 Nov 09, 2023	SELL	$218.65 - $271.46 $8 Million - $9.94 Million	-36,606 Reduced 6.36%	538,941 $145 Million
Q2 2023 Aug 08, 2023	BUY	$214.27 - $253.37 $1.59 Million - $1.88 Million	7,407 Added 1.3%	575,547 $128 Million
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $3.25 Million - $3.97 Million	14,411 Added 2.6%	568,140 $137 Million

Q4 2022 Feb 10, 2023	BUY	$229.03 - $291.01 $4.27 Million - $5.43 Million	18,661 Added 3.49%	553,729 $145 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $2.27 Million - $2.56 Million	10,103 Added 1.92%	535,068 $121 Million
Q2 2022 Aug 09, 2022	SELL	$230.71 - $256.74 $5.43 Million - $6.04 Million	-23,522 Reduced 4.29%	524,965 $128 Million
Q1 2022 May 12, 2022	SELL	$219.27 - $242.57 $5.59 Million - $6.18 Million	-25,479 Reduced 4.44%	548,487 $133 Million
Q4 2021 Feb 09, 2022	SELL	$198.88 - $227.6 $10.7 Million - $12.3 Million	-53,968 Reduced 8.59%	573,966 $129 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $1.18 Million - $1.39 Million	-5,570 Reduced 0.88%	627,934 $134 Million
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $13.3 Million - $14.8 Million	-57,043 Reduced 8.26%	633,504 $154 Million
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $10.9 Million - $12.7 Million	-49,245 Reduced 6.66%	690,547 $167 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $16.1 Million - $19.2 Million	74,625 Added 11.22%	739,792 $170 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $7.49 Million - $8.33 Million	31,940 Added 5.04%	665,167 $169 Million
Q2 2020 Sep 11, 2020	BUY	$197.81 - $242.74 $28.2 Million - $34.6 Million	142,676 Added 29.08%	633,227 $149 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $22.6 Million - $27.7 Million	-114,126 Reduced 18.87%	490,551 $149 Million
Q1 2020 May 13, 2020	BUY	$182.24 - $241.7 $3.91 Million - $5.18 Million	21,436 Added 3.68%	604,677 $123 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $2.93 Million - $3.76 Million	-15,465 Reduced 2.58%	583,241 $141 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $9.86 Million - $11.8 Million	56,605 Added 10.44%	598,706 $117 Million
Q2 2019 Aug 07, 2019	BUY	$166.7 - $195.41 $4.23 Million - $4.96 Million	25,388 Added 4.91%	542,101 $99.8 Million
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $8.21 Million - $9.26 Million	-45,402 Reduced 8.08%	516,713 $97 Million
Q4 2018 Feb 12, 2019	SELL	$178.4 - $208.25 $444,037 - $518,334	-2,489 Reduced 0.44%	562,115 $109 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $161 Million - $181 Million	-867,356 Reduced 60.57%	564,604 $117 Million
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $4.49 Million - $5.05 Million	-27,054 Reduced 1.85%	1,431,960 $264 Million
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $15.3 Million - $17.9 Million	-90,258 Reduced 5.83%	1,459,014 $249 Million
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $1.5 Million - $1.68 Million	8,894 Added 0.58%	1,549,272 $269 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $258 Million - $294 Million	1,540,378	1,540,378 $287 Million

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.

Account

Mitsubishi Ufj Trust & Banking Corp Amgen Inc Transaction History